Japanese medtech sets up in India
Create Medic, a Japanese medical‑devices firm, plans to expand in India with new sales offices and a ₹100 crore manufacturing facility. The move is presented as a local‑manufacturing bet that will require advice on entity structure, tax, capex planning and local compliance (thehindubusinessline.com).
Japan’s Create Medic is shifting from selling through a distributor in India to building its own local sales network and a planned ₹100 crore factory. (thehindubusinessline.com) The Japanese company has opened a dedicated office in Chennai with an initial ₹5 crore investment and said it plans more offices in Delhi, Kolkata and Ahmedabad. President Osamu Imazawa said the India business could reach ₹100 crore in long-term revenue, though he did not give a timeline in BusinessLine; another report said the target is within a decade. (thehindubusinessline.com) (dtnext.in) Create Medic said the factory would serve India as well as nearby markets and Africa, but the site and timing are still under discussion. The Hindu reported the company is looking at Chennai for the plant and plans to expand its network to Delhi and Mumbai. (thehindubusinessline.com) (thehindu.com) The company makes silicone-based disposable devices, including catheters and feeding-tube products used in urology and gastroenterology. Its English-language corporate site says Create Medic’s core business is medical devices made mainly from silicone rubber. (createmedic.co.jp) (createmedicglobal.com) India is pushing harder to localize medical-device production. Invest India says the country’s import dependency in medical devices fell for the first time in 2023, and the federal government launched a ₹500 crore scheme in November 2024 to support components, clinical studies, skills and common infrastructure through fiscal 2026-27. (investindia.gov.in) (pib.gov.in) That backdrop helps explain why a mid-sized Japanese manufacturer is choosing India for both sales and production. The Department of Pharmaceuticals’ scheme page shows the medical-device support program was later updated in June 2025 and February 2026, suggesting the policy push is still being actively shaped. (pharma-dept.gov.in) Create Medic is not entering from zero. The Hindu reported the 50-year-old company began operating in India in 2017 through distributor Medi Nippon, and a 2023 distributor note said Medinippon handled market survey, registration and promotion for Create Medic’s gastrostomy kit in India. (thehindu.com) (medinippon.com) The company is also using India as a product-development base, not only a sales market. Managing director Katsuaki Yamane said Create Medic wants to work with Indian doctors on India-focused products, while naming hospitals such as All India Institute of Medical Sciences, Tata Memorial and Christian Medical College among current users. (dtnext.in) (newindianexpress.com) Create Medic’s own history page says the company moved to the Tokyo Stock Exchange’s Standard Market in April 2022, and The Hindu said it is now making India a direct operating market instead of a distributor-led one. The next signal to watch is whether the Chennai office is followed by a final factory site, licenses and capital spending approvals. (createmedic.co.jp) (thehindu.com)
